dalteparin has been researched along with Hemorrhage, Intracranial, Traumatic in 5 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The incidence of pulmonary embolism (2." | 1.91 | Early venous thromboembolism prophylaxis in patients with trauma intracranial hemorrhage: Analysis of the prospective multicenter Consortium of Leaders in Traumatic Thromboembolism study. ( Chien, CY; Inaba, K; Knudson, MM; Martin, MJ; Matsushima, K; Moore, EE; Sauaia, A; Schellenberg, M; Wu, YT, 2023) |
| "Anticoagulant therapy (ACT) after traumatic intracranial hemorrhage may lead to progression of hemorrhage, but in the presence of thromboembolic events, the clinician must decide if the benefits outweigh the risks." | 1.51 | Use of Anticoagulation Agents After Traumatic Intracranial Hemorrhage. ( Choi, A; Divito, A; Kerr, K; Kitagawa, RS; Shepard, S; Wilkerson, C, 2019) |
| "A deep vein thrombosis was identified in 2 (2%) of 106 patients." | 1.31 | Prospective evaluation of the safety of enoxaparin prophylaxis for venous thromboembolism in patients with intracranial hemorrhagic injuries. ( Berne, JD; Grahm, TW; Kerns, DB; McAuley, CE; McLarty, JW; Norwood, SH; Short, K; Vallina, VL, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, YT | 1 |
| Chien, CY | 1 |
| Matsushima, K | 1 |
| Schellenberg, M | 1 |
| Inaba, K | 1 |
| Moore, EE | 1 |
| Sauaia, A | 1 |
| Knudson, MM | 1 |
| Martin, MJ | 1 |
| Divito, A | 1 |
| Kerr, K | 1 |
| Wilkerson, C | 1 |
| Shepard, S | 1 |
| Choi, A | 1 |
| Kitagawa, RS | 1 |
| Depew, AJ | 1 |
| Hu, CK | 1 |
| Nguyen, AC | 1 |
| Driessen, N | 1 |
| Sen, O | 1 |
| Sonmez, E | 1 |
| Cekinmez, M | 1 |
| Ozen, O | 1 |
| Caner, H | 1 |
| Norwood, SH | 1 |
| McAuley, CE | 1 |
| Berne, JD | 1 |
| Vallina, VL | 1 |
| Kerns, DB | 1 |
| Grahm, TW | 1 |
| Short, K | 1 |
| McLarty, JW | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Use of Low Molecular Weight Heparin in Traumatic Brain Injury[NCT00170378] | Phase 4 | 300 participants | Interventional | 2002-12-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 other studies available for dalteparin and Hemorrhage, Intracranial, Traumatic
| Article | Year |
|---|---|
Early venous thromboembolism prophylaxis in patients with trauma intracranial hemorrhage: Analysis of the prospective multicenter Consortium of Leaders in Traumatic Thromboembolism study.
Topics: Anticoagulants; Enoxaparin; Heparin; Humans; Intracranial Hemorrhage, Traumatic; Intracranial Hemorr | 2023 |
Use of Anticoagulation Agents After Traumatic Intracranial Hemorrhage.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Enoxaparin; Female; Heparin; Humans; Int | 2019 |
Thromboembolic prophylaxis in blunt traumatic intracranial hemorrhage: a retrospective review.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Enoxaparin; Female; Follow-Up Studies; H | 2008 |
Antithrombin III and enoxaparin treatment inhibit contusion-triggered cell death, inflammation, hemorrhage and apoptosis after severe traumatic brain injury in rats.
Topics: Animals; Anticoagulants; Antithrombin III; Antithrombins; Apoptosis; Brain Injuries; Disease Models, | 2011 |
Prospective evaluation of the safety of enoxaparin prophylaxis for venous thromboembolism in patients with intracranial hemorrhagic injuries.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Enoxaparin; Humans; Intracranial Hemorrh | 2002 |